{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:41:19Z","timestamp":1776451279510,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lions Foundation"},{"DOI":"10.13039\/501100017237","name":"Hans-Gabriel och Alice Trolle-Wachtmeisters stiftelse f\u00f6r medicinsk forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bioactive adrenomedullin (bio-ADM) is a vasoactive peptide with a key role in reducing vascular hyperpermeability and improving endothelial stability during infection, but it also has vasodilatory properties. Bioactive ADM has not been studied in conjunction with acute respiratory distress syndrome (ARDS), but it has recently been shown to correlate with outcomes after severe COVID-19. Therefore, this study investigated the association between circulating bio-ADM on intensive care unit (ICU) admission and ARDS. The secondary aim was the association between bio-ADM and ARDS mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed bio-ADM levels and assessed the presence of ARDS in adult patients admitted to two general intensive care units in southern Sweden. Medical records were manually screened for the ARDS Berlin criteria. The association between bio-ADM levels and ARDS and mortality in ARDS patients was analysed using logistic regression and receiver-operating characteristics analysis. The primary outcome was an ARDS diagnosis within 72\u00a0h of ICU admission, and the secondary outcome was 30-day mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 1224 admissions, 11% (<jats:italic>n<\/jats:italic> = 132) developed ARDS within 72\u00a0h. We found that elevated admission bio-ADM level was associated with ARDS independently of\u00a0sepsis status and of organ dysfunction as measured by the Sequential organ failure assessment (SOFA) score. Both <jats:italic>lower<\/jats:italic> levels (&lt; 38 pg\/L) and high (&gt; 90 pg\/L) levels of bio-ADM were independently (of the Simplified acute physiology score, SAPS-3) predictive of mortality. Patients with indirect mechanisms of lung injury had higher bio-ADM levels than those with a direct mechanism of injury, and bio-ADM increased with increasing ARDS severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>High levels of bio-ADM on admission are associated with ARDS, and bio-ADM levels significantly differ depending on the injury mechanism. In contrast, both high and low levels of bio-ADM are associated with mortality, possibly due to the dual action of bio-ADM in stabilising the endothelial barrier and causing vasodilation. These findings could lead to improved diagnostic accuracy of ARDS and potentially lead to new therapeutic strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40635-023-00494-7","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:03:24Z","timestamp":1677801804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma bioactive adrenomedullin on intensive care unit admission is associated with acute respiratory distress syndrome: an observational study"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2444-4701","authenticated-orcid":false,"given":"Patrik","family":"Johnsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fredriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Frigyesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"7511","key":"494_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","volume":"2","author":"DG Ashbaugh","year":"1967","unstructured":"Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2(7511):319\u2013323","journal-title":"Lancet"},{"issue":"8","key":"494_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"GEA Bellani","year":"2016","unstructured":"Bellani GEA (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8):788\u2013800","journal-title":"JAMA"},{"issue":"23","key":"494_CR3","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS, Ranieri V, Rubenfeld GD, Thompson B, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Vincent JL, Bersten A, Needham D, Pesenti A (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526\u20132533","journal-title":"JAMA"},{"issue":"19","key":"494_CR4","first-page":"1904","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD (2017) Acute respiratory distress syndrome. N Engl J Med 377(19):1904\u20131905","journal-title":"N Engl J Med"},{"issue":"4","key":"494_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/cells8040342","volume":"8","author":"JT Ito","year":"2019","unstructured":"Ito JT, Louren\u00e7o JD, Righetti RF, Tib\u00e9rio IFLC, Prado CM, Lopes FDTQS (2019) Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies? Cells 8(4):342","journal-title":"Cells"},{"issue":"7","key":"494_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.2017.21907","volume":"319","author":"E Fan","year":"2018","unstructured":"Fan E, Brodie D, Slutsky AS (2018) Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA 319(7):698\u2013710","journal-title":"JAMA"},{"key":"494_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-018-0202-y","volume":"16","author":"S Spadaro","year":"2019","unstructured":"Spadaro S, Park M, Turrini C, Tunstall T, Thwaites R, Mauri T, Ragazzi R, Ruggeri P, Hansel TT, Caramori G, Volta CA (2019) Biomarkers for acute respiratory distress syndrome and prospects for personalised medicine. J Inflamm (London) 16:1","journal-title":"J Inflamm (London)"},{"issue":"1","key":"494_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-0039-1684049","volume":"40","author":"JP Reilly","year":"2019","unstructured":"Reilly JP, Calfee CS, Christie JD (2019) Acute respiratory distress syndrome phenotypes. Semin Respir Crit Care Med 40(1):19\u201330","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"494_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bbrc.2012.08.022","volume":"425","author":"K Kitamura","year":"2012","unstructured":"Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T, Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (2012) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. 1993. Biochem Biophys Res Commun 425(3):548\u2013555","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"494_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0024-3205(99)00358-6","volume":"66","author":"M Jougasaki","year":"2000","unstructured":"Jougasaki M, Burnett JC (2000) Adrenomedullin: potential in physiology and pathophysiology. Life Sci 66(10):855\u2013872","journal-title":"Life Sci"},{"issue":"9","key":"494_CR11","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1210\/endo.136.9.7649118","volume":"136","author":"A Martinez","year":"1995","unstructured":"Martinez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F (1995) Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 136(9):4099\u20134105","journal-title":"Endocrinology"},{"issue":"2","key":"494_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ejhf.1366","volume":"21","author":"AA Voors","year":"2019","unstructured":"Voors AA, Kremer D, Geven C, Ter Maaten JM, Struck J, Bergmann A, Pickkers P, Metra M, Mebazaa A, D\u00fcngen HD, Butler J (2019) Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail 21(2):163\u2013171","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"494_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.1365-2125.1997.00622.x","volume":"44","author":"JR Cockcroft","year":"1997","unstructured":"Cockcroft JR, Noon JP, Gardner-Medwin J, Bennett T (1997) Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels. Br J Clin Pharmacol 44(1):57\u201360","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"494_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/01.RES.0000036603.61868.F9","volume":"91","author":"S Hippenstiel","year":"2002","unstructured":"Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, Kr\u00fcll M, Seybold J, Seeger W, Rascher W, Sch\u00fctte H, Suttorp N (2002) Adrenomedullin reduces endothelial hyperpermeability. Circ Res 91(7):618\u2013625","journal-title":"Circ Res"},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"29003","DOI":"10.1038\/srep29003","volume":"6","author":"A Garc\u00eda Ponce","year":"2016","unstructured":"Garc\u00eda Ponce A, Cital\u00e1n Madrid AF, Vargas Robles H, Ch\u00e1nez Paredes S, Nava P, Betanzos A, Zarbock A, Rottner K, Vestweber D, Schnoor M (2016) Loss of cortactin causes endothelial barrier dysfunction via disturbed adrenomedullin secretion and actomyosin contractility. Sci Rep 6:29003","journal-title":"Sci Rep"},{"issue":"1","key":"494_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/cc13731","volume":"18","author":"R Marino","year":"2014","unstructured":"Marino R, Struck J, Maisel AS, Magrini L, Bergmann A, Di Somma S (2014) Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis. Crit Care 18(1):34","journal-title":"Crit Care"},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2243-2","volume":"22","author":"A Mebazaa","year":"2018","unstructured":"Mebazaa A, Geven C, Hollinger A, Wittebole X, Chousterman BG, Blet A, Gayat E, Hartmann O, Scigalla P, Struck J, Bergmann A, Antonelli M, Beishuizen A, Constantin JM, Damoisel C, Deye N, Di Somma S, Dugernier T, Francois B, Gaudry S, Huberlant V, Lascarrou JB, Marx G, Mercier E, Oueslati H, Pickkers P, Sonneville R, Legrand M, Laterre PF, Adren OSSSI (2018) Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational adrenomedullin and outcome in sepsis and septic shock-1 (adrenoss-1) study. Crit Care 22:1\u201312","journal-title":"Crit Care"},{"issue":"1","key":"494_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s13054-020-03351-1","volume":"24","author":"OHM Lundberg","year":"2020","unstructured":"Lundberg OHM, Lengquist M, Sp\u00e5ngfors M, Annborn M, Bergmann D, Schulte J, Levin H, Melander O, Frigyesi A, Friberg H (2020) Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness. Crit Care 24(1):636","journal-title":"Crit Care"},{"issue":"2","key":"494_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SHK.0000000000001103","volume":"50","author":"C Geven","year":"2018","unstructured":"Geven C, Bergmann A, Kox M, Pickkers P (2018) Vascular effects of adrenomedullin and the anti-adrenomedullin antibody adrecizumab in sepsis. Shock 50(2):132\u2013140","journal-title":"Shock"},{"issue":"11","key":"494_CR20","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","volume":"47","author":"PF Laterre","year":"2021","unstructured":"Laterre PF, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T, Huberlant V, Schuerholz T, Fran\u00e7ois B, Lascarrou JB, Beishuizen A, Oueslati H, Contou D, Hoiting O, Lacherade JC, Chousterman B, Pottecher J, Bauer M, Godet T, Karakas M, Helms J, Bergmann A, Zimmermann J, Richter K, Hartmann O, Pars M, Mebazaa A, Castanares D, Collienne C, G\u00e8rards L, Hantson P, Montiel V, Berghe C, Dujardin MF, Gielens L, Renard S, Jorens P, Asfar P, Plantef\u00e8ve G, Duranteau J, Weiss E, Vuillard C, Fedou AL, Goudelin M, Evrard B, Daix T, Desachy A, Vignon P, Duchambon AA, Baudrillart L, Bourzeix P, Gay A, Prevost C, Chalot C, Herafa I, Engels P, Ma\u00eblle M, Abeud LF, Berton L, Cerlinskaite K, Deye N, Fournier MC, Hadjam T, Hollinger A, Javanainen T, Jourdaine C, Legrand M, Louadah B, Neuschwander A, Clere-Jehl R, Demiselle J, Merdji H, Monnier A, Mercier E, Kluge S, Zarbock A, van Zanten ARH, Vermeijden W, Dormans T (2021) Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial. Intensive Care Med 47(11):1284\u20131294","journal-title":"Intensive Care Med"},{"issue":"12","key":"494_CR21","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/thx.2010.135996","volume":"65","author":"HC M\u00fcller","year":"2010","unstructured":"M\u00fcller HC, Witzenrath M, Tschernig T, Gutbier B, Hippenstiel S, Santel A, Suttorp N, Rosseau S (2010) Adrenomedullin attenuates ventilator-induced lung injury in mice. Thorax 65(12):1077\u20131084","journal-title":"Thorax"},{"issue":"2","key":"494_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/cc13830","volume":"18","author":"HC M\u00fcller-Redetzky","year":"2014","unstructured":"M\u00fcller-Redetzky HC, Will D, Hellwig K, Kummer W, Tschernig T, Pfeil U, Paddenberg R, Menger MD, Kershaw O, Gruber AD, Weissmann N, Hippenstiel S, Suttorp N, Witzenrath M (2014) Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: protection by adrenomedullin. Crit Care 18(2):73","journal-title":"Crit Care"},{"issue":"8","key":"494_CR23","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/jcm10081667","volume":"10","author":"TP Simon","year":"2021","unstructured":"Simon TP, Stoppe C, Breuer T, Stiehler L, Dreher M, Kersten A, Kluge S, Karakas M, Zechendorf E, Marx G, Martin L (2021) Prognostic value of bioactive adrenomedullin in critically ill patients with COVID-19 in Germany: an observational cohort study. J Clin Med 10(8):1667","journal-title":"J Clin Med"},{"issue":"5","key":"494_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1515\/cclm-2020-1295","volume":"59","author":"C Gregoriano","year":"2021","unstructured":"Gregoriano C, Koch D, Kutz A, Haubitz S, Conen A, Bernasconi L, Hammerer-Lercher A, Saeed K, Mueller B, Schuetz P (2021) The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study. Clin Chem Lab Med 59(5):995\u20131004","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"494_CR25","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/biom10081171","volume":"10","author":"M Karakas","year":"2020","unstructured":"Karakas M, Jarczak D, Becker M, Roedl K, Addo MM, Hein F, Bergmann A, Zimmermann J, Simon TP, Marx G, L\u00fctgehetmann M, Nierhaus A, Kluge S (2020) Targeting endothelial dysfunction in eight extreme-critically ill patients with COVID-19 using the anti-adrenomedullin antibody adrecizumab (HAM8101). Biomolecules 10(8):1171","journal-title":"Biomolecules"},{"issue":"9596","key":"494_CR26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453\u20131457","journal-title":"Lancet"},{"issue":"8","key":"494_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"5","key":"494_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"10","key":"494_CR29","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00134-005-2763-5","volume":"31","author":"RP Moreno","year":"2005","unstructured":"Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall J-R (2005) SAPS 3\u2014from evaluation of the patient to evaluation of the intensive care unit part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 31(10):1345\u20131355","journal-title":"Intensive Care Med"},{"issue":"7","key":"494_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707\u2013710","journal-title":"Intensive Care Med"},{"issue":"8","key":"494_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/aas.13647","volume":"64","author":"M Lengquist","year":"2020","unstructured":"Lengquist M, Lundberg OHM, Sp\u00e5ngfors M, Annborn M, Levin H, Friberg H, Frigyesi A (2020) Sepsis is underreported in Swedish intensive care units: a retrospective observational multicentre study. Acta Anaesthesiol Scand 64(8):1167\u20131176","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"494_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1373\/jalm.2017.023655","volume":"2","author":"J Weber","year":"2019","unstructured":"Weber J, Sachse J, Bergmann S, Sparwa\u00dfer A, Struck J, Bergmann A (2019) Sandwich immunoassay for bioactive plasma adrenomedullin. J Appl Lab Med 2(2):222\u2013233. https:\/\/doi.org\/10.1373\/jalm.2017.023655","journal-title":"J Appl Lab Med"},{"issue":"8","key":"494_CR33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","volume":"27","author":"T Fawcett","year":"2006","unstructured":"Fawcett T (2006) An introduction to roc analysis. Pattern Recogn Lett 27(8):861\u2013874. https:\/\/doi.org\/10.1016\/j.patrec.2005.10.010","journal-title":"Pattern Recogn Lett"},{"key":"494_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"3","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 3:837","journal-title":"Biometrics"},{"key":"494_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1183\/09031936.03.00420803","volume":"42","author":"P Pelosi","year":"2003","unstructured":"Pelosi P, D\u2019Onofrio D, Chiumello D, Paolo S, Chiara G, Capelozzi VL, Barbas CS, Chiaranda M, Gattinoni L (2003) Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl 42:48\u201356","journal-title":"Eur Respir J Suppl"},{"issue":"6","key":"494_CR36","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1378\/chest.14-2454","volume":"147","author":"CS Calfee","year":"2015","unstructured":"Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, Ware LB (2015) Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 147(6):1539\u20131548","journal-title":"Chest"},{"issue":"5","key":"494_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/cc13080","volume":"17","author":"LB Ware","year":"2013","unstructured":"Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR, May AK, Calfee CS, Matthay MA (2013) Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care 17(5):253","journal-title":"Crit Care"},{"issue":"4","key":"494_CR38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.bja.2021.05.038","volume":"127","author":"GM Albaiceta","year":"2021","unstructured":"Albaiceta GM, Brochard L, Dos Santos CC, Fern\u00e1ndez R, Georgopoulos D, Girard T, Jubran A, L\u00f3pez-Aguilar J, Mancebo J, Pelosi P, Skrobik Y, Thille AW, Wilcox ME, Blanch L (2021) The central nervous system during lung injury and mechanical ventilation: a narrative review. Br J Anaesth 127(4):648\u2013659","journal-title":"Br J Anaesth"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-023-00494-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-023-00494-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-023-00494-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:04:30Z","timestamp":1677801870000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-023-00494-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1186\/s40635-023-00494-7","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Ethical Committee in Lund, Sweden, with reference numbers DNR 2015\/267 and DNR 2020\/02395. Patients who did not consent to participate could withdraw through an opt-out procedure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests, no financial or other interests in SphingoTec GmbH and have not been influenced by SphingoTec GmbH in writing this research paper. Bioactive ADM was analysed free of charge by SphingoTec GmbH, Neuendorfstra\u00dfe 15A, 16761 Hennigsdorf, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}